
Danish Centre for AI Innovation (DCAI) operates Gefion, Denmark's first AI supercomputer, providing advanced GPU-based computing power to accelerate AI research and innovation across academia, startups, and enterprises. Funded by the Novo Nordisk Foundation and EIFO, DCAI supports diverse AI applications including life sciences, healthcare, green transition, and quantum computing. Gefion, powered by NVIDIA DGX SuperPod technology, ranks 21st on the Top500 list and enables large-scale computational projects such as drug discovery, simulation, and AI model development. DCAI collaborates with leading organizations like Novo Nordisk, which uses Gefion to transform pharmaceutical R&D with AI-driven protein engineering and biological modeling, aiming to reduce development timelines and unlock new therapies. The company operates on a GPU-based fee model and fosters a community of innovators through workshops and events, positioning itself as a key player in AI supercomputing and innovation in Denmark and globally.

Danish Centre for AI Innovation (DCAI) operates Gefion, Denmark's first AI supercomputer, providing advanced GPU-based computing power to accelerate AI research and innovation across academia, startups, and enterprises. Funded by the Novo Nordisk Foundation and EIFO, DCAI supports diverse AI applications including life sciences, healthcare, green transition, and quantum computing. Gefion, powered by NVIDIA DGX SuperPod technology, ranks 21st on the Top500 list and enables large-scale computational projects such as drug discovery, simulation, and AI model development. DCAI collaborates with leading organizations like Novo Nordisk, which uses Gefion to transform pharmaceutical R&D with AI-driven protein engineering and biological modeling, aiming to reduce development timelines and unlock new therapies. The company operates on a GPU-based fee model and fosters a community of innovators through workshops and events, positioning itself as a key player in AI supercomputing and innovation in Denmark and globally.